About the absolute need to keep active research on the efficacy of direct-acting antiviral drugs against the hepatitis C virus
Author:
Publisher
Elsevier BV
Subject
Hepatology
Reference15 articles.
1. Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life;Guedj;Proc Natl Acad Sci U S A,2013
2. Kinetic analyses reveal early and potent inhibition of hepatitis C virus assembly by NS5A inhibitors;McGivern;Gastroenterology,2014
3. EASL recommendations on treatment of hepatitis C 2018;J Hepatol,2018
4. Retreatment of hepatitis C virus-infected patients with direct-acting antiviral failures;Pawlotsky;Semin Liver Dis,2019
5. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource;Smith;Hepatology,2014
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir;Organic Process Research & Development;2022-02-18
2. Hepatitis C virus: A critical approach to who really needs treatment;World Journal of Hepatology;2022-01-27
3. The 2020 Nobel Prize in Physiology or Medicine;Journal of Medicinal Chemistry;2020-11-05
4. Adaptive Immune Response against Hepatitis C Virus;International Journal of Molecular Sciences;2020-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3